Shenggang Sun

2.3k total citations
88 papers, 1.9k citations indexed

About

Shenggang Sun is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Shenggang Sun has authored 88 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cellular and Molecular Neuroscience, 32 papers in Molecular Biology and 28 papers in Neurology. Recurrent topics in Shenggang Sun's work include Parkinson's Disease Mechanisms and Treatments (26 papers), Neuroscience and Neuropharmacology Research (18 papers) and Nuclear Receptors and Signaling (13 papers). Shenggang Sun is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (26 papers), Neuroscience and Neuropharmacology Research (18 papers) and Nuclear Receptors and Signaling (13 papers). Shenggang Sun collaborates with scholars based in China, United States and Australia. Shenggang Sun's co-authors include Zhihou Liang, Yan Wu, Xuebing Cao, You Shang, Nian Xiong, Rengang Liu, Zhentao Zhang, Cheng‐Xin Gong, Khalid Iqbal and Jinsha Huang and has published in prestigious journals such as PLoS ONE, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Shenggang Sun

88 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenggang Sun China 23 569 498 494 460 401 88 1.9k
Jon‐Son Kuo Taiwan 27 615 1.1× 704 1.4× 371 0.8× 384 0.8× 401 1.0× 78 2.3k
Sudhakar Subramaniam United States 11 570 1.0× 477 1.0× 798 1.6× 377 0.8× 422 1.1× 19 1.7k
Anmu Xie China 25 723 1.3× 397 0.8× 743 1.5× 407 0.9× 350 0.9× 99 2.1k
Masakazu Ibi Japan 25 627 1.1× 550 1.1× 372 0.8× 482 1.0× 236 0.6× 46 2.2k
Yam Nath Paudel Malaysia 27 793 1.4× 468 0.9× 300 0.6× 397 0.9× 521 1.3× 60 2.3k
Chunjiu Zhong China 25 823 1.4× 357 0.7× 811 1.6× 918 2.0× 397 1.0× 61 2.8k
Gyung Whan Kim South Korea 27 1.2k 2.1× 460 0.9× 287 0.6× 405 0.9× 523 1.3× 62 2.5k
Hyung Hwan Baik South Korea 28 724 1.3× 298 0.6× 229 0.5× 402 0.9× 439 1.1× 49 2.0k
Asako Yoritaka Japan 20 690 1.2× 584 1.2× 1.2k 2.3× 436 0.9× 311 0.8× 48 2.2k
Zhihou Liang China 25 912 1.6× 599 1.2× 327 0.7× 1.0k 2.2× 417 1.0× 48 2.4k

Countries citing papers authored by Shenggang Sun

Since Specialization
Citations

This map shows the geographic impact of Shenggang Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenggang Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenggang Sun more than expected).

Fields of papers citing papers by Shenggang Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenggang Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenggang Sun. The network helps show where Shenggang Sun may publish in the future.

Co-authorship network of co-authors of Shenggang Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Shenggang Sun. A scholar is included among the top collaborators of Shenggang Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenggang Sun. Shenggang Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Shenggang, et al.. (2021). Path planning method for spacecraft formation reconfiguration based on CGAPIO. Beijing Hangkong Hangtian Daxue xuebao. 47(2). 223. 1 indexed citations
2.
Wang, Ying, Shenggang Sun, Suiqiang Zhu, et al.. (2016). Analysis of pramipexole dose–response relationships in Parkinson's disease. Drug Design Development and Therapy. Volume11. 83–89. 8 indexed citations
3.
Liu, Yudong, Ying Su, Jiajia Wang, et al.. (2013). Rapamycin decreases tau phosphorylation at Ser214 through regulation of cAMP-dependent kinase. Neurochemistry International. 62(4). 458–467. 56 indexed citations
5.
Chen, Xiao‐Wu, et al.. (2012). [Adenovirus vector mediated human 14-3-3 γ gene transfer protects dopaminergic cells against rotenone-induced injury].. PubMed. 92(1). 55–9. 1 indexed citations
6.
Li, Gang, et al.. (2012). Long term effects of tetramine poisoning: An observational study. Clinical Toxicology. 50(3). 172–175. 13 indexed citations
7.
Wu, Yan, Yanping Wang, Longyan Li, et al.. (2012). Aspirin-Triggered Lipoxin A4 Attenuates Lipopolysaccharide-Induced Intracellular ROS in BV2 Microglia Cells by Inhibiting the Function of NADPH Oxidase. Neurochemical Research. 37(8). 1690–1696. 49 indexed citations
8.
Ding, Jun, et al.. (2012). Fibroblast growth factor-2 counteracts the effect of ciliary neurotrophic factor on spontaneous differentiation in adult hippocampal progenitor cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 32(6). 867–871. 3 indexed citations
9.
Xiong, Nian, Jing Xiong, Chunnuan Chen, et al.. (2011). Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease. PLoS ONE. 6(6). e20677–e20677. 64 indexed citations
10.
Zhang, Zhentao, Xuebing Cao, Nian Xiong, et al.. (2010). Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo. Acta Pharmacologica Sinica. 31(8). 900–906. 96 indexed citations
11.
Xiong, Nian, Jinsha Huang, Zhentao Zhang, et al.. (2009). Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease. PLoS ONE. 4(11). e7878–e7878. 95 indexed citations
12.
Wang, Puqing, Shenggang Sun, & Xian Qiao. (2009). [Protective effects of doxycycline upon dopaminergic neuron in LPS-induced rat model of Parkinson's disease].. PubMed. 89(19). 1346–50. 2 indexed citations
13.
Zhang, Zhentao, Tao Wang, Xuebing Cao, Shenggang Sun, & Lan Wang. (2009). 6-OHDA induces cycle reentry and apoptosis of PC12 cells through activation of ERK1/2 signaling pathway. Journal of Huazhong University of Science and Technology [Medical Sciences]. 29(1). 97–100. 6 indexed citations
14.
Wu, Yan, You Shang, Shenggang Sun, & Rengang Liu. (2007). Antioxidant effect of erythropoietin on 1-methyl-4-phenylpyridinium-induced neurotoxicity in PC12 cells. European Journal of Pharmacology. 564(1-3). 47–56. 43 indexed citations
15.
Tian, You‐Yong, Shenggang Sun, Cuiju Tang, et al.. (2006). Intrastriatal gene transfer of vascular endothelial growth factor rescues dopaminergic neurons in a rat Parkinson’s disease model. Journal of Huazhong University of Science and Technology [Medical Sciences]. 26(6). 670–673. 2 indexed citations
16.
Li, Gang, et al.. (2004). Protective effect of S-methylisourea against the degeneration of dopaminergic neurons induced by intranigral injection of lipopolysaccharide. 1 indexed citations
17.
Guan, Jingxia, et al.. (2004). Experimental study on the PAR-1 expression around hemotoma following intracerebral hemorrhage in rats. Current Medical Science. 24(3). 266–268. 7 indexed citations
18.
Wang, Tao, Zhihou Liang, Shenggang Sun, et al.. (2003). [A novel point mutation in parkin gene was identified in an early-onset case of Parkinson's disease].. PubMed. 20(2). 111–3. 11 indexed citations
19.
Wang, Tao, et al.. (2003). Point mutation in the parkin gene on patients with Parkinson’s disease. Current Medical Science. 23(2). 145–147. 8 indexed citations
20.
Sun, Shenggang, et al.. (2002). Features of endoplasmic reticulum calcium stores in rat astrocytes. 18(3). 596–601. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026